insights_auto
Why is EDIT down 4,09%?
Dive Deeperchevron_right
EDIT:NASDAQ
Editas Medicine Inc
1,64 US$
arrow_downward
-4,09%(-0,070) 1D
1,66 US$
arrow_upward
+1,22% (+0,020)bedtimeAfter hours
Closed: 20 ნოე, 16:00:00 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
1,69 US$
High
1,78 US$
Low
1,63 US$
Mkt. cap
253,12 მლნ.
Avg. vol.
2,24 მლნ.
Volume
2,68 მლნ.
52-wk high
3,94 US$
52-wk low
1,63 US$
EPS
-0,62 US$
Beta
2,09
Shares outstanding
154,34 მლნ.
No. of employees
87
Open
1,69 US$
High
1,78 US$
Low
1,63 US$
Mkt. cap
253,12 მლნ.
Avg. vol.
2,24 მლნ.
Volume
2,68 მლნ.
52-wk high
3,94 US$
52-wk low
1,63 US$
EPS
-0,62 US$
Beta
2,09
Shares outstanding
154,34 მლნ.
No. of employees
87
News stories
From web sources and news partners
The Motley Fool
·
37 წუთის წინ
The S&P 500 Is 14 for 14 After Midterm Elections. Here’s How I’d Invest Now.
TradingKey
·
10 საათის წინ
S&P 500 Falls Below 200-Day Moving Average: Buy-the-Dip Opportunity or Bear Market Warning?
Beinsure
·
14 საათის წინ
Vanguard S&P 500 ETF: How investing in VOO could build a $1 mn portfolio
StoneX
·
2 დღის წინ
S&P 500, Nasdaq 100 Drive into Correction Territory
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc